Showing posts with label Alzheimer's. Show all posts
Showing posts with label Alzheimer's. Show all posts

04 June 2009

Possible cause of Alzheimer’s disease caused by hyperphosphorylation of tau proteins may have a genetic link.

A recent discovery by researchers at McGill University and Lady Davis Research Institute for Medical Research at Montreal's Jewish General Hospital promises to help in the diagnosis and curing of Alzheimer’s disease. They found that in patients will AD, there was a hyperphosphorylation (extra phosphate added) to one of the amino acids on a tau protein in the CNS. The 6 isoforms of Tau proteins are involved in the stabilisation of microtubules by their reaction with tubulin. When they are hyperphosphorylated, it causes a protein cascade with interaction between tau proteins resulting in neurofibrillary tangles that cause the neuron transport system to fail. This causes incorrect signals to be sent, and eventually neuron death. These tangles often occur in older individuals, but not on nearly as large a scale as in a patient with AD. A protein called beta-amyloid that builds up in neurons is also associated with AD, and thought to help cause cell death by interrupting cell homeostasis, causing apoptosis. By investigating the cause of this hyperphosphorylation, and build up of beta-amyloids, researchers hope to eventually find a cure for AD, as they believe that this hyperphosphorylation may be genetically linked. APOE is a gene that is present in 50% of late-onset Alzheimer’s disease cases. Genetic interpretation of this gene could help to find a cure, and genetic modification of this gene in embryos could also help to cure it.


This discovery is very important, as Alzheimer’s disease is a very prominent disease in society’s elderly, and can have disastrous effects, such as initially short-term memory loss, then as the disease progresses, resulting in greater cognitive degeneration, confusion, irritability, mood swings, language breakdown and long-term memory loss. This draws on many of the concepts covered in the course, such as protein interactions, protein cascades, genetic modification and interpretation.




http://www.ncbi.nlm.nih.gov/pubmed/11801334

http://www.genengnews.com/genCasts.aspx

Andrew Buchan - s4202068

15 May 2009

Warning Signs: A New Test to Predict Alzheimer's


Researchers at the University of California, San Francisco (UCSF), and the University of Pittsburgh have developed the first screening tool that can help predict whether elderly patients are at low, moderate or high risk of developing dementia. The new test takes into account characteristic risk factors for dementia, including advanced age and the presence of genes

Barnes and her colleagues studied 3,375 patients age 65 years or older. Researchers recorded which of the patients developed dementia in the six-year study period, then isolated the risk factors that appeared to make dementia more likely. Volunteers who scored eight points or higher on the index — which includes older age, worse cognitive function, some heart disease risk factors and the presence of genes linked to Alzheimer's — were at high risk of developing dementia within six years.

The research team found that patients who were underweight, did not drink alcohol and took longer to put on and button a shirt were also at high risk for dementia. Barnes speculates that people who drink alcohol may simply be healthier overall and therefore less vulnerable than others to mental decline. "It's possible that someone who is still enjoying a glass of wine each day is in better health," Barnes says.

The screening tool may be extremely useful in prompting high-risk people to start doing whatever they can to protect themselves from future memory loss. So, what should high scorers do? For one, they can build a rich social network of friends and family, and engage aggressively in ways that challenge their mental as well as physical capabilities.

http://www.time.com/time/health/article/0,8599,1898034,00.html?imw=Y

22 March 2009

Mutant gene causes and protects against Alzheimer's

Fabrizio Tagliavini and fellow researchers at the National Neurological Institute in Italy have recently discovered a gene mutation which may both cause and prevent the onset of Alzheimer's

The gene ,named APP, creates β-amyloid, a protein found to affect the brains neuron receptors. β-amyloid proteins bind together within the brain and prevent the communication of neurons. Many scientists believe that this "clumping" affect causes Alzheimer symptoms to occur including memory loss and speech difficulty.


Tagliavini's investigation into the gene focused around a family whose members all had the mutated gene in either homozygous or heterozygous form. They found that those with the homozygous form contracted Alzheimer's early in life or had cognitive problems. On the other hand, members with the heterozygous form showed no signs of Alzheimer's.

Further experiments were conducted on the protein created by the mutated gene. Tagliavini's team mixed the mutated and normal protein together and found that there was minimal "clumping". Surprisingly even less than the mutant protein and normal protein alone. Tagliavini suggested that this minimal clumping could aid in the prevention of Alzheimer's.

For those with homozygous APP, Tagliavini found that another mutant protein which is extremely small (only 6 units in length) was able to prevent the β-amyloid from blocking the neurons however he was unable to synthetically create the protein inside of Alzheimer patients.

Although a very small percentage of Alzheimer patients have this gene mutation, it is hoped that scientists may one day be able to replicate this mutation, thus preventing the onset of Alzheimer's. Although Tagliavini admits "we are very far away from this point", it is still an exciting break through for neurology community.

References:
1. Giuseppe Di Fede et al, March 2009, A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis, DOI 10.1126/science.1168979. Retrieved on the 22 March 2009 from
http://www.sciencemag.org/cgi/content/abstract/sci;323/5920/1473?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=Alzheimer+Fabrizio+Tagliavini&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
2. Ewen Callaway, March 2009, Paradoxical gene causes and protects against Alzheimer's. Retrieved on the 22 March 2009 from
http://www.newscientist.com/article/dn16750-paradoxical-gene-causes-and-protects-against-alzheimers.html

3. Alzheimers [Image], n.d., Retrieved on the 22 March 2009 from
http://topnews.in/healthcare/sites/default/files/Alzheimers56.jpg

By 42053266

APP - Causing and Protecting from Alzheimer's

Permanent changes and genetic mutations can cause diseases such as Alzheimer's. These genes can be inherited from parents.
I chose this topic as I find it amazing that scientists can pick the EXACT gene that causes such a dominant disease in our society. Anything that can help put a stop or help us control this, is more than welcome research.
There are two types of Alzheimer's Disease: early-onset and late-onset both of which have genetic links, however, the study of the APP gene is mostly on late-onset.

<span class=

The new discovery of the APP gene has made some causes of late-onset Alzheimer's clearer.
Gene mutation on chromosomes which cause chromosome proteins is the major cause. APP makes the protein A-beta, which form together in the brain and block functions such as speech and memory leading to Alzheimer's.
In terms of heredity, if only one copy of the mutated APP gene is inherited from both parents, less A-beta proteins can form therefore making the occurrence of Alzheimer's Disease less likely; forming a sort of protection against the disease.

The discovery of this A-beta protein means that the conditions that occur in the 'one copy' brain can be mimicked using drugs. This means that the body can form its own 'protection' even if a person has two copies of the mutated gene.
Whether this treatment works or not, the discovery of the APP mutation changes the way Alzheimer's Disease is looked at even though it is known that even one copy of the gene is enough to cause the disease.

<span class=

References:
1. http://kclmlc.files.wordpress.com/2008/02/dna_alzheimers.jpg
2. http://www.newscientist.com/article/dn16750-paradoxical-gene-causes-and-protects-against-alzheimers.html?full=true&print=true
3.http://www.nia.nih.gov/Alzheimers/Publications/geneticsfs.htm
4. http://www.topnews.in/health/files/alzheimers-brain.jpg4. 

15 March 2009

APP Genes Unique Part in Hereditary Alzheimer’s


Alzheimer's is a progressive, terminal brain disease and is the leading cause of dementia. Scientists at the “Carlo Besta" National Neurological Institute in Milan, Italy have discovered a gene mutation that seems to give protection when inherited from only one parent but causes Alzheimer’s when two copies are inherited. Fabrizio Tagliavini, who along with his colleagues, discovered this mutation hope that this research will lead to the development of new drug therapies that can be used to treat both genetic and sporadic forms of the disease.

The gene mutation found occurs in APP, which makes a protein known as A-beta, is often linked to familial cases of Alzheimer’s. Although only a small proportion of the millions Alzheimer’s cases are linked to single, inherited mutations, this particular mutation is unique in that it needs to be inherited from both parents to cause the disease. Most mutations already identified are dominant and require only one copy to produce the disease.

The mutation was discovered in a patient with signs of early onset Alzheimer’s, but no mutations in other genes associated with the inheritable form of the disease. For further research, cells were taken from a 44-year old man with early onset Alzheimer’s that had two copies of the APP mutation. It was found that his A-beta proteins developed clumps more often then cells from people with normal APP gene. One theory for the cause of Alzheimer’s is linked to the development of such clumps.

Relatives of the early onset Alzheimer’s patient with only one copy of the mutant APP gene did not show any symptoms of the disease, including an 88-year old aunt. This was backed up by the observation that when normal and mutant forms of A-beta were mixed together, there were even less clumps than with the normal protein alone. Indicating that inheritance of only one mutant allele of APP may protect a person from Alzheimer’s disease.

Tugliavini and his colleagues hope the creation of a synthetic protein could be used to recreate the mixture of proteins that reduces clumping in patients with two copies of the mutant gene. In fact his team has found a mutant protein that reduces clumping of the proteins. It is only six units long which hopefully increase the chances of successful travel through out the body.

Even if a drug is not developed the APP mutation discovery will change how scientists view the genetics of Alzheimer’s.


Articles:
http://www.newscientist.com/article/dn16750-paradoxical-gene-causes-and-protects-against-alzheimers.html
http://www.sciencedaily.com/releases/2009/03/090312140846.htm
http://www.sciencemag.org.ezproxy.library.uq.edu.au/cgi/content/full/sci;323/5920/1473?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=tagliavini&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

Other Sources:
http://en.wikipedia.org/wiki/Alzheimer's_disease
http://www.alz.org/alzheimers_disease_what_is_alzheimers.asp